Ayed O. Ayed

405 total citations
11 papers, 153 citations indexed

About

Ayed O. Ayed is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Ayed O. Ayed has authored 11 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Ayed O. Ayed's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Ayed O. Ayed is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Ayed O. Ayed collaborates with scholars based in United States, Italy and Ukraine. Ayed O. Ayed's co-authors include Jan S. Moreb, Lung‐Ji Chang, Caitlin B. Conboy, Ayalew Tefferi, Inuk Zandvakili, Elizabeth Cathcart-Rake, John D. Reith, Xiaomin Lu, Thomas J. George and Abdalla Awidi and has published in prestigious journals such as Blood, American Journal of Clinical Pathology and Critical Reviews in Oncology/Hematology.

In The Last Decade

Ayed O. Ayed

10 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayed O. Ayed United States	6	83	50	41	39	37	11	153
Tuğrul Elverdi Türkiye	7	71 0.9×	63 1.3×	48 1.2×	34 0.9×	37 1.0×	44	164
Kseniya Petrova‐Drus United States	7	53 0.6×	43 0.9×	54 1.3×	31 0.8×	80 2.2×	20	183
Luigi Petrucci Italy	8	61 0.7×	71 1.4×	60 1.5×	28 0.7×	49 1.3×	24	167
Andrea Aroldi Italy	10	65 0.8×	64 1.3×	52 1.3×	36 0.9×	19 0.5×	22	168
Jeeyeon Baik United States	6	61 0.7×	31 0.6×	76 1.9×	28 0.7×	73 2.0×	18	151
Arturo Bonometti Italy	9	50 0.6×	63 1.3×	34 0.8×	20 0.5×	43 1.2×	34	185
Susanna Grassi Italy	8	102 1.2×	105 2.1×	57 1.4×	23 0.6×	47 1.3×	17	233
Nicola Sgherza Italy	8	98 1.2×	73 1.5×	37 0.9×	26 0.7×	11 0.3×	33	196
Esperanza Lavilla Spain	8	82 1.0×	36 0.7×	100 2.4×	23 0.6×	49 1.3×	12	200
Steven Hanson United Kingdom	6	37 0.4×	54 1.1×	28 0.7×	156 4.0×	38 1.0×	8	218

Countries citing papers authored by Ayed O. Ayed

Since Specialization

Citations

This map shows the geographic impact of Ayed O. Ayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayed O. Ayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayed O. Ayed more than expected).

Fields of papers citing papers by Ayed O. Ayed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayed O. Ayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayed O. Ayed. The network helps show where Ayed O. Ayed may publish in the future.

Co-authorship network of co-authors of Ayed O. Ayed

This figure shows the co-authorship network connecting the top 25 collaborators of Ayed O. Ayed. A scholar is included among the top collaborators of Ayed O. Ayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayed O. Ayed. Ayed O. Ayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Sharman, Jeff P., Aung M. Tun, José C. Villasboas, et al.. (2025). Fixed treatment duration subcutaneous mosunetuzumab monotherapy in elderly/unfit patients with previously untreated diffuse large B-cell lymphoma: Interim results from the Phase II MorningSun study. Blood. 146(Supplement 1). 62–62.

Barrientos, Jacqueline C., Ayed O. Ayed, Bruno Fang, et al.. (2023). Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences. Targeted Oncology. 18(5). 727–734. 1 indexed citations

Zandvakili, Inuk, Caitlin B. Conboy, Ayed O. Ayed, Elizabeth Cathcart-Rake, & Ayalew Tefferi. (2018). Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience. American Journal of Hematology. 93(5). 35 indexed citations

Ayed, Ayed O., Annalisa Chiappella, Levi Pederson, et al.. (2018). CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies. Blood Cancer Journal. 8(7). 63–63. 16 indexed citations

Ayed, Ayed O. & Sameer A. Parikh. (2017). Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy. Leukemia & lymphoma. 59(10). 2287–2296. 5 indexed citations

Malecek, Mary‐Kate, Adam M. Petrich, Steven Trifilio, et al.. (2017). Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab. American Journal of Hematology. 92(11). 1156–1162. 8 indexed citations

Ayed, Ayed O., Annalisa Chiappella, Grzegorz S. Nowakowski, et al.. (2016). Lenalidomide Plus R-CHOP (R2CHOP) in Patients with DLBCL Is Associated with a Lower Risk of CNS Relapse: Combined Analysis from Two Phase 2 Studies. Blood. 128(22). 3033–3033. 2 indexed citations

Ayed, Ayed O., Lung‐Ji Chang, & Jan S. Moreb. (2015). Immunotherapy for multiple myeloma: Current status and future directions. Critical Reviews in Oncology/Hematology. 96(3). 399–412. 26 indexed citations

Reith, John D., et al.. (2015). Interobserver Variability of Mitotic Index and Utility of PHH3 for Risk Stratification in Gastrointestinal Stromal Tumors. American Journal of Clinical Pathology. 143(3). 385–392. 25 indexed citations

10.

Ayed, Ayed O., Jan S. Moreb, Jack W. Hsu, et al.. (2014). Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma. Blood. 124(21). 5761–5761. 2 indexed citations

11.

Awidi, Abdalla, et al.. (2010). Relationship of serum imatinib trough level and response in CML patients: Long term follow-up. Leukemia Research. 34(12). 1573–1575. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact